Loading…

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine

Saved in:

Bibliographic Details
Published in:	Leukemia & lymphoma 2013-08, Vol.54 (8), p.1786-1787
Main Authors:	Breccia, Massimo, Fianchi, Luana, Lunghi, Monia, Gaidano, Gianluca, Levis, Alessandro, Finelli, Carlo, Santini, Valeria, Musto, Pellegrino, Mansueto, Giovanna, Oliva, Esther N., Leoni, Pietro, Spiriti, Maria Antonietta Aloe, Hohaus, Stefan, Leone, Giuseppe, Alimena, Giuliana, Voso, Maria Teresa
Format:	Article
Language:	English
Subjects:	Antimetabolites, Antineoplastic - therapeutic use Azacitidine - therapeutic use Humans Myelodysplastic Syndromes - chemically induced Myelodysplastic Syndromes - drug therapy Myelodysplastic Syndromes - mortality Neoplasms, Second Primary - chemically induced Neoplasms, Second Primary - drug therapy Neoplasms, Second Primary - mortality Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!